Cytomed Therapeutics announces receipt of Nasdaq notification regarding minimum bid price deficiency
GDTC•Cytomed Therapeutics said it received a Nasdaq notification regarding a minimum bid price deficiency.
1. Nasdaq notification
Cytomed Therapeutics announced that it received a Nasdaq notification regarding a minimum bid price deficiency.
